Bringing Clarity to Brain Trauma

Clear TBI NeuroLabs delivers advanced biomarker testing designed to provide objective clinical insight for concussion and TBI care. This science-backed approach supports evaluation beyond symptom-based assessment, with findings that may inform estimation of temporal onset and guide clinical decision-making.

Objective. Disruptive. Next-Level Care.

Objective Clinical Insight Backed by Biomarker Science

Clear TBI NeuroLabs delivers advanced biomarker and genetic testing designed to provide objective clinical insight into concussion and traumatic brain injury.

Our science-backed diagnostic approach helps providers evaluate measurable biological responses while supporting more accurate assessment of injury timing, recovery patterns, and neurological impact.

Focused on clear, objective data and temporal accuracy, our testing delivers clinically relevant insight to support informed decision-making and patient care.

Concussion & TBI Evaluation
Advanced Biomarker Testing

Advanced Biomarker Testing for Concussion & TBI Care

Our science-backed testing panels help providers evaluate neuroinflammation, neuronal injury, recovery patterns, and long-term neurological risk using clinically relevant biomarkers and genetic insights.

Designed for real-world clinical application, Clear TBI testing supports:

  • Objective concussion assessment
  • TBI recovery monitoring
  • Long-term neurological risk evaluation
  • Personalized patient management strategies

Why Providers Use Clear TBI

Built for Modern TBI & Concussion Practices

Evidence-Based Biomarker Testing

Evidence-Based Biomarker Testing

Simple Blood & Swab Collection

Simple Blood & Swab Collection

Actionable Clinical Insight

Actionable Clinical Insight

Provider-Focused Support

Provider-Focused Support

Clear TBI NeuroLabs combines advanced diagnostics with streamlined collection methods and provider-focused workflows to help practices integrate biomarker testing into everyday care.

Genetic Insights Beyond Immediate Injury

Genetic markers such as APOE and MTHFR may provide additional insight into inflammation response, neurological recovery, and potential long-term risk following traumatic brain injury. When combined with biomarker analysis, providers gain a more comprehensive view of patient variability and recovery potential.
Genetic Insights
RedDrop ONE

Simplified
Sample Collection

Clear TBI NeuroLabs utilizes modern collection technologies including the RedDrop ONE and Tasso to support convenient, efficient blood sample collection with minimal disruption to patients and clinical staff.

Designed for ease of use in both clinical and remote collection settings.

Bring Objective Data Into TBI Care

Schedule a Demo or Request More Information

Move beyond symptom-based evaluation with advanced concussion and TBI biomarker testing designed for modern providers. Fill out the form below, and one of our clinical partners will follow up shortly.

Scroll to Top